DE602006002650D1 - Verfahren zur Herstellung von Paroxetin Hydrochlorid Hemihydrat - Google Patents

Verfahren zur Herstellung von Paroxetin Hydrochlorid Hemihydrat

Info

Publication number
DE602006002650D1
DE602006002650D1 DE602006002650T DE602006002650T DE602006002650D1 DE 602006002650 D1 DE602006002650 D1 DE 602006002650D1 DE 602006002650 T DE602006002650 T DE 602006002650T DE 602006002650 T DE602006002650 T DE 602006002650T DE 602006002650 D1 DE602006002650 D1 DE 602006002650D1
Authority
DE
Germany
Prior art keywords
paroxetine hydrochloride
preparation
hydrochloride hemihydrate
hemihydrate
crystalline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602006002650T
Other languages
English (en)
Inventor
Franca Segnalini
Stefano Magnanti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apotecnia S A
Original Assignee
Apotecnia S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apotecnia S A filed Critical Apotecnia S A
Publication of DE602006002650D1 publication Critical patent/DE602006002650D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602006002650T 2005-05-26 2006-05-22 Verfahren zur Herstellung von Paroxetin Hydrochlorid Hemihydrat Expired - Fee Related DE602006002650D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68523705P 2005-05-26 2005-05-26

Publications (1)

Publication Number Publication Date
DE602006002650D1 true DE602006002650D1 (de) 2008-10-23

Family

ID=36969441

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006002650T Expired - Fee Related DE602006002650D1 (de) 2005-05-26 2006-05-22 Verfahren zur Herstellung von Paroxetin Hydrochlorid Hemihydrat

Country Status (4)

Country Link
EP (1) EP1726591B1 (de)
JP (1) JP2007008918A (de)
AT (1) ATE407933T1 (de)
DE (1) DE602006002650D1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100797983B1 (ko) * 2006-11-01 2008-01-24 정태석 통행요금 수납장치 및 이를 이용한 수납시스템
PL2508523T5 (pl) † 2007-10-23 2020-08-10 Teva Pharmaceutical Industries Ltd. Odmiany polimorficzne dasatynibu i sposób ich wytwarzania
JP2010260826A (ja) * 2009-05-08 2010-11-18 Sumitomo Chemical Co Ltd パロキセチン塩酸塩半水和物の製造方法
CN112641750A (zh) * 2021-01-12 2021-04-13 江苏睿实生物科技有限公司 一种盐酸帕罗西汀片剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223403B1 (de) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
GB9920147D0 (en) * 1999-08-25 1999-10-27 Smithkline Beecham Plc Novel process
WO2003057150A2 (en) * 2001-12-28 2003-07-17 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof
JP4394004B2 (ja) * 2002-09-19 2010-01-06 住友化学株式会社 結晶析出方法
WO2007054978A2 (en) * 2005-11-10 2007-05-18 Jubilant Organosys Limited Process for preparing paroxetine hydrochloride hemihydrate

Also Published As

Publication number Publication date
ATE407933T1 (de) 2008-09-15
EP1726591B1 (de) 2008-09-10
EP1726591A2 (de) 2006-11-29
JP2007008918A (ja) 2007-01-18
EP1726591A3 (de) 2007-07-25

Similar Documents

Publication Publication Date Title
ATE544754T1 (de) Verfahren zur herstellung von ivabradinhydrochlorid
EA201200954A1 (ru) Способ получения полугидрата гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1н-3-бензазепина, фармацевтическая композиция на его основе и его применение
WO2005095379A3 (en) Crystalline methanesulfonic acid addition salts of imatinib
EP1672077A4 (de) Verfahren zur herstellung von bernsteinsäure
ATE537136T1 (de) Neues verfahren zur herstellung von säurechloriden
ATE444950T1 (de) Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid
ATE554086T1 (de) Scopin-salze und deren verwendung in verfahren zur herstellung von n-demethyl-tiotropium und tiotropiumbromid
PE20050078A1 (es) Derivados de pirrolidona como inhibidores de maob
DE50307242D1 (de) Verfahren zum herstellen von einkristallinen strukturen
DE602006021411D1 (de) Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren
IL183591A0 (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
DE60304119D1 (de) Verfahren zur Herstellung von dünnwandigen gleichartigen Gitterstrukturen
ATE441627T1 (de) Verfahren zur herstellung von valsartan
DE602006002650D1 (de) Verfahren zur Herstellung von Paroxetin Hydrochlorid Hemihydrat
DE602004020916D1 (de) Verfahren zum Herstellen von hochreinem Hafnium
EP1669460A4 (de) Biokatalysator zur herstellung von d-milchsäure
ITMI20051970A1 (it) Processo per la preparazione di eteri misti derivanti dall'inaftolo e intermedi di forme cristalline definite di + e - duloxetina
ATE549315T1 (de) Verfahren zur herstellung von kristallinem perindopril
AU2003299300A1 (en) METHOD FOR THE PRODUCTION OF R-Alpha-LIPOIC ACID BY FERMENTATION
ATE466010T1 (de) Verfahren zur herstellung von candesartan
ATE523490T1 (de) Verfahren zur herstellung von pleuromutilinen
ATE512134T1 (de) Verfahren zur herstellung von 5-benzyloxy-2-(4- benzyloxyphenyl)-3-methyl-1h-indol
BRPI0408752A (pt) processo para o preparo de um polimorfo de maleato de rosiglitazona
DE602005013007D1 (de) Verfahren zur herstellung von lactonen
ATE403418T1 (de) Verfahren zur herstellung von festen dosierformen von amorphem valganciclovir-hydrochlorid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee